These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 20708332)

  • 1. Familial early onset frontotemporal dementia caused by a novel S356T MAPT mutation, initially diagnosed as schizophrenia.
    Momeni P; Wickremaratchi MM; Bell J; Arnold R; Beer R; Hardy J; Revesz T; Neal JW; Morris HR
    Clin Neurol Neurosurg; 2010 Dec; 112(10):917-20. PubMed ID: 20708332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic heterogeneity in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) due to microtubule-associated protein tau (MAPT) p.P301L mutation, including a patient with globular glial tauopathy.
    Tacik P; Sanchez-Contreras M; DeTure M; Murray ME; Rademakers R; Ross OA; Wszolek ZK; Parisi JE; Knopman DS; Petersen RC; Dickson DW
    Neuropathol Appl Neurobiol; 2017 Apr; 43(3):200-214. PubMed ID: 27859539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Closing the tau loop: the missing tau mutation.
    McCarthy A; Lonergan R; Olszewska DA; O'Dowd S; Cummins G; Magennis B; Fallon EM; Pender N; Huey ED; Cosentino S; O'Rourke K; Kelly BD; O'Connell M; Delon I; Farrell M; Spillantini MG; Rowland LP; Fahn S; Craig P; Hutton M; Lynch T
    Brain; 2015 Oct; 138(Pt 10):3100-9. PubMed ID: 26297556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frontotemporal dementia with the V337M
    Spina S; Schonhaut DR; Boeve BF; Seeley WW; Ossenkoppele R; O'Neil JP; Lazaris A; Rosen HJ; Boxer AL; Perry DC; Miller BL; Dickson DW; Parisi JE; Jagust WJ; Murray ME; Rabinovici GD
    Neurology; 2017 Feb; 88(8):758-766. PubMed ID: 28130473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and Pathological Features of FTDP-17 with MAPT p.K298_H299insQ Mutation.
    Morino H; Kurashige T; Matsuda Y; Ono M; Sahara N; Miyasaka T; Soeda Y; Shimada H; Yamazaki Y; Takahashi T; Izumi Y; Ito H; Maruyama H; Higuchi M; Arihiro K; Suhara T; Takashima A; Kawakami H
    Mov Disord Clin Pract; 2024 Jun; 11(6):720-727. PubMed ID: 38605589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical, pathological, and genetic characteristics of frontotemporal dementia and parkinsonism linked to chromosome 17 with mutations in the MAPT and PGRN].
    Tsuboi Y
    Brain Nerve; 2009 Nov; 61(11):1285-91. PubMed ID: 19938685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical heterogeneity of frontotemporal dementia and Parkinsonism linked to chromosome 17 caused by MAPT N279K mutation in relation to tau positron emission tomography features.
    Ikeda A; Shimada H; Nishioka K; Takanashi M; Hayashida A; Li Y; Yoshino H; Funayama M; Ueno Y; Hatano T; Sahara N; Suhara T; Higuchi M; Hattori N
    Mov Disord; 2019 Apr; 34(4):568-574. PubMed ID: 30773680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel MAPT mutation K298E: mechanisms of mutant tau toxicity, brain pathology and tau expression in induced fibroblast-derived neurons.
    Iovino M; Pfisterer U; Holton JL; Lashley T; Swingler RJ; Calo L; Treacy R; Revesz T; Parmar M; Goedert M; Muqit MM; Spillantini MG
    Acta Neuropathol; 2014 Feb; 127(2):283-95. PubMed ID: 24292008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrafamilial variable phenotype including corticobasal syndrome in a family with p.P301L mutation in the MAPT gene: first report in South America.
    Gatto EM; Allegri RF; Da Prat G; Chrem Mendez P; Hanna DS; Dorschner MO; Surace EI; Zabetian CP; Mata IF
    Neurobiol Aging; 2017 May; 53():195.e11-195.e17. PubMed ID: 28268100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FTDP-17 with Pick body-like inclusions associated with a novel tau mutation, p.E372G.
    Tacik P; DeTure MA; Carlomagno Y; Lin WL; Murray ME; Baker MC; Josephs KA; Boeve BF; Wszolek ZK; Graff-Radford NR; Parisi JE; Petrucelli L; Rademakers R; Isaacson RS; Heilman KM; Petersen RC; Dickson DW; Kouri N
    Brain Pathol; 2017 Sep; 27(5):612-626. PubMed ID: 27529406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The genetics of dementias. Part 1: Molecular basis of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)].
    Kowalska A
    Postepy Hig Med Dosw (Online); 2009 Jun; 63():278-86. PubMed ID: 19535823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MAPT mutation associated with frontotemporal dementia and parkinsonism (FTDP-17).
    Haussmann R; Wysocki M; Brandt MD; Hermann A; Donix M
    Int Psychogeriatr; 2017 May; 29(5):869-871. PubMed ID: 27905268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invited review: Frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging.
    Ghetti B; Oblak AL; Boeve BF; Johnson KA; Dickerson BC; Goedert M
    Neuropathol Appl Neurobiol; 2015 Feb; 41(1):24-46. PubMed ID: 25556536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau PET Imaging with [18F]PM-PBB3 in Frontotemporal Dementia with MAPT Mutation.
    Su Y; Fu J; Yu J; Zhao Q; Guan Y; Zuo C; Li M; Tan H; Cheng X
    J Alzheimers Dis; 2020; 76(1):149-157. PubMed ID: 32444551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-MK-6240 tau-PET in genetic frontotemporal dementia.
    Levy JP; Bezgin G; Savard M; Pascoal TA; Finger E; Laforce R; Sonnen JA; Soucy JP; Gauthier S; Rosa-Neto P; Ducharme S
    Brain; 2022 Jun; 145(5):1763-1772. PubMed ID: 34664612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frontotemporal dementia and parkinsonism linked to chromosome 17--the first Polish family.
    Narożańska E; Jasińska-Myga B; Sitek EJ; Robowski P; Brockhuis B; Lass P; Dubaniewicz M; Wieczorek D; Baker M; Rademakers R; Wszolek ZK; Sławek J
    Eur J Neurol; 2011 Mar; 18(3):535-7. PubMed ID: 20561037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synaptic gene expression changes in frontotemporal dementia due to the MAPT 10 + 16 mutation.
    Dando O; McGeachan R; McQueen J; Baxter P; Rockley N; McAlister H; Prasad A; He X; King D; Rose J; Jones PB; Tulloch J; Chandran S; Smith C; Hardingham G; Spires-Jones TL
    Neuropathol Appl Neurobiol; 2024 Aug; 50(4):e13006. PubMed ID: 39164997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frontotemporal dementia with parkinsonism linked to chromosome 17 with the MAPT R406W mutation presenting with a broad distribution of abundant senile plaques.
    Ishida C; Kobayashi K; Kitamura T; Ujike H; Iwasa K; Yamada M
    Neuropathology; 2015 Feb; 35(1):75-82. PubMed ID: 25377499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of extent of tau pathology in patients with frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17), frontotemporal lobar degeneration with Pick bodies and early onset Alzheimer's disease.
    Shiarli AM; Jennings R; Shi J; Bailey K; Davidson Y; Tian J; Bigio EH; Ghetti B; Murrell JR; Delisle MB; Mirra S; Crain B; Zolo P; Arima K; Iseki E; Murayama S; Kretzschmar H; Neumann M; Lippa C; Halliday G; Mackenzie J; Khan N; Ravid R; Dickson D; Wszolek Z; Iwatsubo T; Pickering-Brown SM; Mann DM
    Neuropathol Appl Neurobiol; 2006 Aug; 32(4):374-87. PubMed ID: 16866983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of reactive microglia and neuroinflammatory mediators in a case of frontotemporal dementia with P301S mutation.
    Bellucci A; Bugiani O; Ghetti B; Spillantini MG
    Neurodegener Dis; 2011; 8(4):221-9. PubMed ID: 21212632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.